drug research

  • May 3, 2014  

    Pfizer made a $106 billion bid for the British drug maker AstraZeneca this week in a move that was potentially motivated by lower corporate tax rates overseas. The deal could also affect the development of new drugs. Hari Sreenivasan speaks with Bloomberg news reporter Shannon Pettypiece about how mergers affect drug research. Continue reading

  • March 21, 2007  

    A new Alzheimer’s Association report says the number of people with Alzheimer’s is on the rise and, while elderly people still represent the vast majority of cases, as many as 500,000 people under age 65 are living with the disease. An association member explains. Continue reading